Skip to main navigation Skip to search Skip to main content

The Functional Characterization of Venous Thromboembolic Disease (FUVID) study: rationale, design, and methods of a prospective, observational, multicenter study to evaluate mechanisms of exercise intolerance and dyspnea following pediatric pulmonary embolism

  • FUVID Investigators
  • University of Texas Southwestern Medical Center
  • University of Texas at Arlington
  • Children's Health System of Texas
  • Cook Children's Medical Center
  • Texas Children's Hospital Houston
  • University of Arkansas for Medical Sciences
  • Pennsylvania State University
  • Children's Hospital of Philadelphia
  • Harvard University
  • Children's Hospital Oklahoma City
  • Central Michigan University
  • Riley Children's Hospital
  • Emory University
  • Children's Mercy Kansas City
  • Johns Hopkins University
  • Northwestern University
  • Nationwide Children’s Hospital
  • University of California at San Diego
  • St. Jude Children Research Hospital
  • St. Lukes Children's Cancer Institute
  • University of Cincinnati
  • University of Michigan, Ann Arbor
  • University of Alabama at Birmingham
  • Leiden University
  • Medical University of Vienna
  • Institute of Exercise and Environmental Science

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Background: To date, the focus of investigation in pediatric pulmonary embolism (PE) has been on PE recurrence and anticoagulant-related bleeding. While highly relevant, these outcomes do not fully capture functional limitations and the psychological impact that comprises post-PE syndrome. Objectives: The primary objective of the Functional Characterization of Venous Thromboembolic Disease (FUVID) study was to investigate mechanisms of post-PE syndrome in children. Methods: The ongoing FUVID study will prospectively enroll and systematically follow, over 12 months and with standardized pulmonary, cardiac, and muscle testing, a multicenter prospective cohort of 80 pediatric patients with first-episode PE without comorbidities. FUVID has 2 coprimary outcomes: exercise intolerance and exertional dyspnea. Exercise intolerance will be defined objectively as a percent predicted peak oxygen uptake based on ideal body weight or milliliters per minute per kilogram of lean body mass during cardiopulmonary exercise testing. Dyspnea will be objectively quantified using Borg questionnaires and defined as a mean difference of >1 at the end of the warm-up and submaximal work rates during exercise testing, simulating conditions during daily life that induce dyspnea. Pertinent secondary outcomes include anxiety, depression, and quality of life. Conclusion: The FUVID study will investigate the relationship between symptoms (exercise intolerance and exertional dyspnea) and multiple mechanisms—hemodynamic, ventilatory, or peripheral/muscle—within the same patient at rest, submaximal exercise (simulating activities of daily living), and maximal exercise using objective measures. It will provide new evidence for selecting patients for long-term follow-up, including psychological sequelae, after PE, the modalities this follow-up should include, and the findings interpreted as indicating functional limitations after PE.

Original languageEnglish
Article number102669
JournalResearch and Practice in Thrombosis and Haemostasis
Volume9
Issue number1
DOIs
StatePublished - Jan 2025

Keywords

  • children
  • pediatrics
  • post–pulmonary embolism syndrome
  • pulmonary embolism
  • venous thromboembolism

Fingerprint

Dive into the research topics of 'The Functional Characterization of Venous Thromboembolic Disease (FUVID) study: rationale, design, and methods of a prospective, observational, multicenter study to evaluate mechanisms of exercise intolerance and dyspnea following pediatric pulmonary embolism'. Together they form a unique fingerprint.

Cite this